OTC Healthcare in the US to 2013

Introduction

This databook provides key data and information on the OTC healthcare market in the US. This report is a comprehensive resource for market, category and segment level data including value, distribution share and company & brand share.

Scope

*Contains information on:analgesics,medicated skin product,topical OTC,traditional,indigestion,cough&cold,plasters&Bandages,vitamins and first aid kits

*Market,category and segment level information on value with historic (2003-2008) and forecast (2009-2013) data

*Category level company and brand share as well as distribution share information for 2007 and 2008

*Category level company and brand share as well as distribution share information for 2007 and 2008

Highlights

The market for OTC healthcare in the US increased at a compound annual growth rate of 3% between 2003 and 2008.

The cough and cold preparations category led the OTC healthcare market in the US, accounting for a share of 23%.

Leading players in the US OTC healthcare market include Johnson & Johnson, Wyeth and Schering-Plough Corporation.

Reasons to Purchase

*Develop business strategies by understanding the quantitative trends within the OTC healthcare market in the US

*Design effective marketing and sales strategies by identifying key market categories and segments

*Identify key players within the market to plan lucrative M&A, partnerships and agreements


Report Highlights

[Studien Infos ausblenden]

TABLE OF CONTENTS
Chapter 1 Executive Summary 2
Summary market level: OTC healthcare 2
Summary category level: analgesics 3
Summary category level: topical OTC medicines 4
Summary category level: cough and cold preparations 5
Summary category level: indigestion preparations 6
Summary category level: medicated skin products 7
Summary category level: first aid kits 8
Summary category level: other OTC healthcare products 9
Summary category level: plasters & bandages 10
Summary category level: traditional medicines 11
Summary category level: vitamins and minerals 12
Chapter 2 Introduction 13
What is this report about? 13
How to use this report 13
Market definition 14
Chapter 3 Market Overview 29
Value analysis (US Dollar), 2003?08 29
Value analysis (US Dollar), 2008?13 31
Company and brand share analysis 33
Distribution analysis 42
Chapter 4 Leading Company Profiles 44
Johnson & Johnson 44
Wyeth 46
Chapter 5 Category Analysis: Analgesics 48
Value analysis (US Dollar), 2003?08 48
Value analysis (US Dollar), 2008?13 49
Company and brand share analysis 51
Distribution analysis 55
Chapter 6 Category Analysis: Topical OTC Medicines 57
Value analysis (US Dollar), 2003?08 57
Value analysis (US Dollar), 2008?13 58
Company and brand share analysis 60
Distribution analysis 62
Chapter 7 Category Analysis: Cough and Cold Preparations 64
Value analysis (US Dollar), 2003?08 64
Value analysis (US Dollar), 2008?13 65
Company and brand share analysis 67
Distribution analysis 72
Chapter 8 Category Analysis: Indigestion Preparations 74
Value analysis (US Dollar), 2003?08 74
Value analysis (US Dollar), 2008?13 75
Company and brand share analysis 77
Distribution analysis 81
Chapter 9 Category Analysis: Medicated Skin Products 83
Value analysis (US Dollar), 2003?08 83
Value analysis (US Dollar), 2008?13 84
Company and brand share analysis 86
Distribution analysis 89
Chapter 10 Category Analysis: First Aid Kits 91
Value analysis (US Dollar), 2003?08 91
Value analysis (US Dollar), 2008?13 92
Company and brand share analysis 93
Distribution analysis 96
Chapter 11 Category Analysis: Other OTC Healthcare Products 98
Value analysis (US Dollar), 2003?08 98
Value analysis (US Dollar), 2008?13 99
Company and brand share analysis 101
Distribution analysis 106
Chapter 12 Category Analysis: Plasters & Bandages 108
Value analysis (US Dollar), 2003?08 108
Value analysis (US Dollar), 2008?13 109
Company and brand share analysis 111
Distribution analysis 114
Chapter 13 Category Analysis: Traditional Medicines 116
Value analysis (US Dollar), 2003?08 116
Value analysis (US Dollar), 2008?13 117
Company and brand share analysis 118
Distribution analysis 120
Chapter 14 Category Analysis: Vitamins and Minerals 122
Value analysis (US Dollar), 2003?08 122
Value analysis (US Dollar), 2008?13 123
Company and brand share analysis 125
Distribution analysis 128
Chapter 15 Country Comparison 130
Value 130
Market share 134
Chapter 16 PESTLE Analysis 135
Summary 135
Political analysis 136
Economic analysis 139
Social analysis 143
Technological analysis 147
Legal analysis 151
Environmental analysis 154
Chapter 17 New Product Development 157
Product launches over time 157
Recent product launches 159
Chapter 18 Macroeconomic Profile 160
Macroeconomic indicators 160
Chapter 19 Research Methodology 165
Methodology overview 165
Secondary research 166
Market modeling 167
Creating an initial data model 167
Revising the initial data model 167
Creating a final estimate 168
Creating demographic value splits 168
Primary research 168
Data finalization 169
Ongoing research 169
Chapter 20 APPENDIX 170
Future readings 170
How to contact experts in your industry 170
Disclaimer 170

LIST OF FIGURES
Figure 1: US OTC healthcare value and value forecast, 2003?13 ($m, nominal prices) 32
Figure 2: US OTC healthcare category growth comparison, by value, 2003?13 32
Figure 3: US OTC healthcare company share, by value, 2007?08 (%) 39
Figure 4: US OTC healthcare distribution channels, by value, 2007?08 (%) 43
Figure 5: US analgesics value and value forecast, 2003?13 ($m, nominal prices) 50
Figure 6: US analgesics category growth comparison, by value, 2003?13 50
Figure 7: US analgesics company share, by value, 2007?08 (%) 53
Figure 8: US analgesics distribution channels, by value, 2007?08 (%) 56
Figure 9: US topical OTC medicines value and value forecast, 2003?13 ($m, nominal prices) 59
Figure 10: US topical OTC medicines category growth comparison, by value, 2003?13 59
Figure 11: US topical OTC medicines distribution channels, by value, 2007?08 (%) 63
Figure 12: US cough and cold preparations value and value forecast, 2003?13 ($m, nominal prices) 66
Figure 13: US cough and cold preparations category growth comparison, by value, 2003?13 66
Figure 14: US cough and cold preparations company share, by value, 2007?08 (%) 69
Figure 15: US cough and cold preparations distribution channels, by value, 2007?08 (%) 73
Figure 16: US indigestion preparations value and value forecast, 2003?13 ($m, nominal prices) 76
Figure 17: US indigestion preparations category growth comparison, by value, 2003?13 76
Figure 18: US indigestion preparations company share, by value, 2007?08 (%) 79
Figure 19: US indigestion preparations distribution channels, by value, 2007?08 (%) 82
Figure 20: US medicated skin products value and value forecast, 2003?13 ($m, nominal prices) 85
Figure 21: US medicated skin products category growth comparison, by value, 2003?13 85
Figure 22: US medicated skin products company share, by value, 2007?08 (%) 87
Figure 23: US medicated skin products distribution channels, by value, 2007?08 (%) 90
Figure 24: US first aid kits value and value forecast, 2003?13 ($m, nominal prices) 92
Figure 25: US first aid kits company share, by value, 2007?08 (%) 94
Figure 26: US first aid kits distribution channels, by value, 2007?08 (%) 97
Figure 27: US other OTC healthcare products value and value forecast, 2003?13 ($m, nominal prices) 100
Figure 28: US other OTC healthcare products category growth comparison, by value, 2003?13 100
Figure 29: US other OTC healthcare products company share, by value, 2007?08 (%) 103
Figure 30: US other OTC healthcare products distribution channels, by value, 2007?08 (%) 107
Figure 31: US plasters & bandages value and value forecast, 2003?13 ($m, nominal prices) 110
Figure 32: US plasters & bandages category growth comparison, by value, 2003?13 110
Figure 33: US plasters & bandages company share, by value, 2007?08 (%) 112
Figure 34: US plasters & bandages distribution channels, by value, 2007?08 (%) 115
Figure 35: US traditional medicines value and value forecast, 2003?13 ($m, nominal prices) 117
Figure 36: US traditional medicines distribution channels, by value, 2007?08 (%) 121
Figure 37: US vitamins and minerals value and value forecast, 2003?13 ($m, nominal prices) 124
Figure 38: US vitamins and minerals category growth comparison, by value, 2003?13 124
Figure 39: US vitamins and minerals company share, by value, 2007?08 (%) 126
Figure 40: US vitamins and minerals distribution channels, by value, 2007?08 (%) 129
Figure 41: Global OTC healthcare market split (value terms, 2008), top five countries 131
Figure 42: Global OTC healthcare market value, 2003–08, top five countries 133
Figure 43: Annual data review process 166

LIST OF TABLES
Table 1: OTC healthcare category definitions 15
Table 2: OTC healthcare distribution channels 17
Table 3: US OTC healthcare value, 2003?08 ($m, nominal prices) 30
Table 4: US OTC healthcare value forecast, 2008?13 ($m, nominal prices) 31
Table 5: US OTC healthcare brand share, by value, 2007?08 (%) 33
Table 6: US OTC healthcare value, by brand 2007?08 ($m, nominal prices) 36
Table 7: US OTC healthcare company share by value, 2007?08 (%) 40
Table 8: US OTC healthcare value, by company, 2007?08 ($m, nominal prices) 41
Table 9: US OTC healthcare distribution channels, by value, 2007?08 (%) 42
Table 10: US OTC healthcare value, by distribution channel, 2007?08 ($m, nominal prices) 42
Table 11: Johnson & Johnson key facts 44
Table 12: Wyeth key facts 46
Table 13: US analgesics value, 2003?08 ($m, nominal prices) 48
Table 14: US analgesics value forecast, 2008?13 ($m, nominal prices) 49
Table 15: US analgesics brand share, by value, 2007?08 (%) 51
Table 16: US analgesics value, by brand 2007?08 ($m, nominal prices) 52
Table 17: US analgesics company share by value, 2007?08 (%) 54
Table 18: US analgesics value, by company, 2007?08 ($m, nominal prices) 54
Table 19: US analgesics distribution channels, by value, 2007?08 (%) 55
Table 20: US analgesics value, by distribution channel, 2007?08 ($m, nominal prices) 55
Table 21: US topical OTC medicines value, 2003?08 ($m, nominal prices) 57
Table 22: US topical OTC medicines value forecast, 2008?13 ($m, nominal prices) 58
Table 23: US topical OTC medicines brand share, by value, 2007?08 (%) 60
Table 24: US topical OTC medicines value, by brand 2007?08 ($m, nominal prices) 60
Table 25: US topical OTC medicines company share by value, 2007?08 (%) 61
Table 26: US topical OTC medicines value, by company, 2007?08 ($m, nominal prices) 61
Table 27: US topical OTC medicines distribution channels, by value, 2007?08 (%) 62
Table 28: US topical OTC medicines value, by distribution channel, 2007?08 ($m, nominal prices) 62
Table 29: US cough and cold preparations value, 2003?08 ($m, nominal prices) 64
Table 30: US cough and cold preparations value forecast, 2008?13 ($m, nominal prices) 65
Table 31: US cough and cold preparations brand share, by value, 2007?08 (%) 67
Table 32: US cough and cold preparations value, by brand 2007?08 ($m, nominal prices) 68
Table 33: US cough and cold preparations company share by value, 2007?08 (%) 70
Table 34: US cough and cold preparations value, by company, 2007?08 ($m, nominal prices) 71
Table 35: US cough and cold preparations distribution channels, by value, 2007?08 (%) 72
Table 36: US cough and cold preparations value, by distribution channel, 2007?08 ($m, nominal prices) 72
Table 37: US indigestion preparations value, 2003?08 ($m, nominal prices) 74
Table 38: US indigestion preparations value forecast, 2008?13 ($m, nominal prices) 75
Table 39: US indigestion preparations brand share, by value, 2007?08 (%) 77
Table 40: US indigestion preparations value, by brand 2007?08 ($m, nominal prices) 78
Table 41: US indigestion preparations company share by value, 2007?08 (%) 80
Table 42: US indigestion preparations value, by company, 2007?08 ($m, nominal prices) 80
Table 43: US indigestion preparations distribution channels, by value, 2007?08 (%) 81
Table 44: US indigestion preparations value, by distribution channel, 2007?08 ($m, nominal prices) 81
Table 45: US medicated skin products value, 2003?08 ($m, nominal prices) 83
Table 46: US medicated skin products value forecast, 2008?13 ($m, nominal prices) 84
Table 47: US medicated skin products brand share, by value, 2007?08 (%) 86
Table 48: US medicated skin products value, by brand 2007?08 ($m, nominal prices) 86
Table 49: US medicated skin products company share by value, 2007?08 (%) 88
Table 50: US medicated skin products value, by company, 2007?08 ($m, nominal prices) 88
Table 51: US medicated skin products distribution channels, by value, 2007?08 (%) 89
Table 52: US medicated skin products value, by distribution channel, 2007?08 ($m, nominal prices) 89
Table 53: US first aid kits value, 2003?08 ($m, nominal prices) 91
Table 54: US first aid kits value forecast, 2008?13 ($m, nominal prices) 92
Table 55: US first aid kits brand share, by value, 2007?08 (%) 93
Table 56: US first aid kits value, by brand 2007?08 ($m, nominal prices) 93
Table 57: US first aid kits company share by value, 2007?08 (%) 95
Table 58: US first aid kits value, by company, 2007?08 ($m, nominal prices) 95
Table 59: US first aid kits distribution channels, by value, 2007?08 (%) 96
Table 60: US first aid kits value, by distribution channel, 2007?08 ($m, nominal prices) 96
Table 61: US other OTC healthcare products value, 2003?08 ($m, nominal prices) 98
Table 62: US other OTC healthcare products value forecast, 2008?13 ($m, nominal prices) 99
Table 63: US other OTC healthcare products brand share, by value, 2007?08 (%) 101
Table 64: US other OTC healthcare products value, by brand 2007?08 ($m, nominal prices) 102
Table 65: US other OTC healthcare products company share by value, 2007?08 (%) 104
Table 66: US other OTC healthcare products value, by company, 2007?08 ($m, nominal prices) 105
Table 67: US other OTC healthcare products distribution channels, by value, 2007?08 (%) 106
Table 68: US other OTC healthcare products value, by distribution channel, 2007?08 ($m, nominal prices) 106
Table 69: US plasters & bandages value, 2003?08 ($m, nominal prices) 108
Table 70: US plasters & bandages value forecast, 2008?13 ($m, nominal prices) 109
Table 71: US plasters & bandages brand share, by value, 2007?08 (%) 111
Table 72: US plasters & bandages value, by brand 2007?08 ($m, nominal prices) 111
Table 73: US plasters & bandages company share by value, 2007?08 (%) 113
Table 74: US plasters & bandages value, by company, 2007?08 ($m, nominal prices) 113
Table 75: US plasters & bandages distribution channels, by value, 2007?08 (%) 114
Table 76: US plasters & bandages value, by distribution channel, 2007?08 ($m, nominal prices) 114
Table 77: US traditional medicines value, 2003?08 ($m, nominal prices) 116
Table 78: US traditional medicines value forecast, 2008?13 ($m, nominal prices) 117
Table 79: US traditional medicines brand share, by value, 2007?08 (%) 118
Table 80: US traditional medicines value, by brand 2007?08 ($m, nominal prices) 118
Table 81: US traditional medicines company share by value, 2007?08 (%) 119
Table 82: US traditional medicines value, by company, 2007?08 ($m, nominal prices) 119
Table 83: US traditional medicines distribution channels, by value, 2007?08 (%) 120
Table 84: US traditional medicines value, by distribution channel, 2007?08 ($m, nominal prices) 120
Table 85: US vitamins and minerals value, 2003?08 ($m, nominal prices) 122
Table 86: US vitamins and minerals value forecast, 2008?13 ($m, nominal prices) 123
Table 87: US vitamins and minerals brand share, by value, 2007?08 (%) 125
Table 88: US vitamins and minerals value, by brand 2007?08 ($m, nominal prices) 125
Table 89: US vitamins and minerals company share by value, 2007?08 (%) 127
Table 90: US vitamins and minerals value, by company, 2007?08 ($m, nominal prices) 127
Table 91: US vitamins and minerals distribution channels, by value, 2007?08 (%) 128
Table 92: US vitamins and minerals value, by distribution channel, 2007?08 ($m, nominal prices) 128
Table 93: Global OTC healthcare market value, 2008 130
Table 94: Global OTC healthcare market split (value terms ($m), 2008), top five countries 133
Table 95: Leading players, top five countries 134
Table 96: Analysis of the US’s political landscape 136
Table 97: Analysis of the US economy 139
Table 98: Analysis of the US’s social system 143
Table 99: Analysis of the US’s technology landscape 147
Table 100: Analysis of the US’s legal landscape 151
Table 101: Analysis of the US’s environmental landscape 154
Table 102: US OTC healthcare new product launches reports, by company (top five companies), 2008 157
Table 103: US OTC healthcare new product launches SKUs, by company (top five companies), 2008 157
Table 104: US OTC healthcare new product launches (reports), by flavor and fragrances (top 10 flavors), 2008 158
Table 105: US OTC healthcare new product launches (reports), by ingredients (top 10 ingredients), 2008 158
Table 106: US OTC healthcare new product launches (reports), by package tags or claims (top 10 claims), 2008 159
Table 107: US OTC healthcare new product launches - recent five launches 2008 159
Table 108: US population, by age group, 2003?08 (millions) 160
Table 109: US population forecast, by age group, 2008?13 (millions) 161
Table 110: US population, by gender, 2003?08 (millions) 161
Table 111: US population forecast, by gender, 2008?13 (millions) 162
Table 112: US nominal GDP, 2003?08 ($bn, nominal prices) 162
Table 113: US nominal GDP forecast, 2008?13 ($bn, nominal prices) 162
Table 114: US real GDP, 2003?08 ($bn, 2000 prices) 163
Table 115: US real GDP forecast, 2008?13 ($bn, 2000 prices) 163
Table 116: US consumer price index, 2003?08 (2000=100) 163
Table 117: US consumer price index, 2008?13 (2000=100) 164



[Inhaltsverzeichnis ausblenden]